NPR

After A Big Failure, Scientists And Patients Hunt For A New Type Of Alzheimer's Drug

Now that so many experimental drugs targeting amyloid-beta have bombed, scientists are looking for different approaches for treating Alzheimer's, including a drug that failed as a cancer treatment.
Phil Gutis with his dog, Abe, who died last year. Gutis, who has Alzheimer's, hoped an experimental drug could help preserve his memories.

Scientists are setting a new course in their quest to treat Alzheimer's disease.

The shift comes out of necessity. A series of expensive failures with experimental drugs aimed at a toxic protein called amyloid-beta have led to a change in approach.

The most recent disappointment came in March, when drugmaker Biogen and its partner Eisai announced they were halting two large clinical trials of an amyloid drug called aducanumab.

"It was like being punched in the stomach," says Phil Gutis, 57, an Alzheimer's patient in one of the

You’re reading a preview, subscribe to read more.

More from NPR

NPR4 min readWorld
China Launches A New Crew To Its Space Station, Advancing Toward Lunar Mission
Three astronauts will spend six months on China's space station. Some experts worry China's ambitious space program could pose a threat to U.S. space superiority and military effectiveness.
NPR5 min readFinance & Money Management
Housing Experts Say There Just Aren't Enough Homes In The U.S.
The United States is millions of homes short of demand, and lacks enough affordable housing units. And many Americans feel like housing costs are eating up too much of their take-home pay.
NPR4 min readInternational Relations
An American Hostage Is Seen Alive For The First Time Since Oct. 7 In A Hamas Video
Hersh Goldberg-Polin, who turned 24 last month while in captivity, has spent more than 200 days in captivity. His left arm was partially blown off by a grenade during the Hamas-led attack on Oct. 7.

Related Books & Audiobooks